Nephro Care India Schedules Board Meeting for Q2 Results and Office Relocation
Nephro Care India Ltd 路 Intimation 路 12 Nov 2026, 5:30 am
Nephro Care India Schedules Board Meeting for Q2 Results and Office Relocation Nephro Care India Limited has scheduled a Board of Directors meeting on 12th Nov'26 to consider and approve the unaudited standalone and consolidated financial results, along with profit/loss statements and cash flows for the quarter and half-year ended 30th Sep'26. The board will also review the Statutory Auditor's Limited Review Report and consider a proposal to shift the company's corporate office to LA Block, Sector 3, Bidhannagar, Kolkata.
Original exchange filing (PDF)
More announcements from Nephro Care India Ltd
- Nephro Care India Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 12 Nov 2026
- Nephro Care India Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32 路 12 Nov 2026
- Nephro Care India Limited has informed the Exchange about related Party Transactions 路 12 Nov 2026
- Nephro Care India Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 12 Nov 2026
- NEPHRO CARE INDIA LIMITED has informed the Exchange about Board Meeting to be held on 12-Nov-2026 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2026 and Other business. 路 12 Nov 2026
- SDD Certificate for the quarter ended 30th September 2026 路 05 Oct 2026
- Nephro Care India Limited has informed regarding Submission of the Compliance Report on Corporate Governance for the quarter ended 30th September 2026 路 01 Oct 2026
- Nephro Care India Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 25, 2026. Further, the company has informed the Exchange regarding voting results. 路 28 Sept 2026
